Oren Pasvolsky

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

Yaël C. Cohen, Mor Zada, Shuang-Yin Wang et al. · Nature Medicine · 2021 · 229 citations · Full text

Hematological Malignancy, Resistance Pathways, Single Cell Sequencing +8

An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis

Adi Zoref‐Lorenz, Jun Murakami, Liron Hofstetter et al. · Blood · 2021 · 131 citations · Full text

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

Jorge J. Castillo, Gilad Itchaki, Jonas Paludo et al. · Blood · 2018 · 98 citations · Full text

Ponatinib reduces viability, migration, and functionality of human endothelial cells

Ayala Gover‐Proaktor, Galit Granot, Saar Shapira et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 71 citations

Immunology, Cell Death, Cellular Physiology +16

Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells

Ayala Gover‐Proaktor, Galit Granot, Metsada Pasmanik‐Chor et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 59 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Angiogenesis +15